Bessemer Group
RETA

Bessemer Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bessemer Group’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
2017
Q4 		$63K Sell
2017
Q3 		$259K Buy
2017
Q2 		$71K Sell
2017
Q1 		$394K Hold
2016
Q4 		$380K Buy